General Information of Drug Off-Target (DOT) (ID: OTYC0I4I)

DOT Name DNA-directed RNA polymerase III subunit RPC6 (POLR3F)
Synonyms RNA polymerase III subunit C6; DNA-directed RNA polymerase III subunit F; RNA polymerase III 39 kDa subunit; RPC39
Gene Name POLR3F
Related Disease
Immunodeficiency 101 (varicella zoster virus-specific) ( )
UniProt ID
RPC6_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2DK5; 2YU3; 7A6H; 7AE1; 7AE3; 7AEA; 7AST; 7D58; 7D59; 7DN3; 7DU2; 7FJI; 7FJJ; 8ITY; 8IUE; 8IUH
Pfam ID
PF05158
Sequence
MAEVKVKVQPPDADPVEIENRIIELCHQFPHGITDQVIQNEMPHIEAQQRAVAINRLLSM
GQLDLLRSNTGLLYRIKDSQNAGKMKGSDNQEKLVYQIIEDAGNKGIWSRDIRYKSNLPL
TEINKILKNLESKKLIKAVKSVAASKKKVYMLYNLQPDRSVTGGAWYSDQDFESEFVEVL
NQQCFKFLQSKAETARESKQNPMIQRNSSFASSHEVWKYICELGISKVELSMEDIETILN
TLIYDGKVEMTIIAAKEGTVGSVDGHMKLYRAVNPIIPPTGLVRAPCGLCPVFDDCHEGG
EISPSNCIYMTEWLEF
Function
DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Specific peripheric component of RNA polymerase III (Pol III) which synthesizes small non-coding RNAs including 5S rRNA, snRNAs, tRNAs and miRNAs from at least 500 distinct genomic loci. Part of POLR3C/RPC3-POLR3F/RPC6-POLR3G/RPC7 heterotrimer that coordinates the dynamics of Pol III stalk and clamp modules during the transition from apo to elongation state. Pol III plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses, including varicella zoster virus. Acts as a nuclear and cytosolic DNA sensor detecting AT-rich DNA, involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF-kappa-B through the RIG-I pathway. Preferentially binds double-stranded DNA (dsDNA).
KEGG Pathway
R. polymerase (hsa03020 )
Cytosolic D.-sensing pathway (hsa04623 )
Reactome Pathway
RNA Polymerase III Chain Elongation (R-HSA-73780 )
RNA Polymerase III Transcription Termination (R-HSA-73980 )
RNA Polymerase III Abortive And Retractive Initiation (R-HSA-749476 )
RNA Polymerase III Transcription Initiation From Type 1 Promoter (R-HSA-76061 )
RNA Polymerase III Transcription Initiation From Type 2 Promoter (R-HSA-76066 )
RNA Polymerase III Transcription Initiation From Type 3 Promoter (R-HSA-76071 )
Cytosolic sensors of pathogen-associated DNA (R-HSA-1834949 )

Molecular Interaction Atlas (MIA) of This DOT

1 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Immunodeficiency 101 (varicella zoster virus-specific) DISY7E97 Limited Unknown [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of DNA-directed RNA polymerase III subunit RPC6 (POLR3F). [2]
TAK-243 DM4GKV2 Phase 1 TAK-243 decreases the sumoylation of DNA-directed RNA polymerase III subunit RPC6 (POLR3F). [7]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of DNA-directed RNA polymerase III subunit RPC6 (POLR3F). [3]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of DNA-directed RNA polymerase III subunit RPC6 (POLR3F). [4]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of DNA-directed RNA polymerase III subunit RPC6 (POLR3F). [3]
Estradiol DMUNTE3 Approved Estradiol increases the expression of DNA-directed RNA polymerase III subunit RPC6 (POLR3F). [5]
Temozolomide DMKECZD Approved Temozolomide increases the expression of DNA-directed RNA polymerase III subunit RPC6 (POLR3F). [6]
Cidofovir DMA13GD Approved Cidofovir decreases the expression of DNA-directed RNA polymerase III subunit RPC6 (POLR3F). [3]
Clodronate DM9Y6X7 Approved Clodronate decreases the expression of DNA-directed RNA polymerase III subunit RPC6 (POLR3F). [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 Varicella-zoster virus CNS vasculitis and RNA polymerase III gene mutation in identical twins. Neurol Neuroimmunol Neuroinflamm. 2018 Sep 7;5(6):e500. doi: 10.1212/NXI.0000000000000500. eCollection 2018 Nov.
2 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
3 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
4 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
5 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
6 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
7 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.